Trademark Alertz ®
Search
Trademark
Owner
Trademark: 2061022
Word
Device Descrption:
WAVY BRUSHSTROKE & IRREGULAR DISC
ID
2061022
Trademark Type
Figurative
Status
Registered: Registered/protected
Application Date
03 January 2020
Registration Date
03 January 2020
Renewal Date
03 January 2030
Owner(s)
Evelo Biosciences Inc
Service
Maddocks
Goods and Services:
Class 5
:
Pharmaceutical preparations and substances
;
pPharmaceuticals used to prevent and treat disease in the nature of cancer, cancer symptoms, cancer-related diseases and side effects of cancer therapies
;
pPharmaceuticals used to prevent disease in the nature of inflammation, neuro-inflammation, and autoimmune diseases
;
pharmaceuticals used to prevent disease in the nature of allergies and disrupted microbial community associated with allergies
;
p Pharmaceuticals used to prevent disease in the nature of metabolic disorders
;
pharmaceuticals used to prevent cardiovascular, neuro-degenerative, and neuro-psychiatric diseases
;
pharmaceuticals used to prevent, treat and cure neoplastic conditions, pre-neoplastic conditions and disrupted microbial community associated with aforementioned conditions in human and animal subjects
;
pharmaceuticals used to prevent, treat and cure inflammation, neuro-inflammation, and autoimmune diseases and disrupted microbial community associated with aforementioned conditions in human and animal subjects
;
pharmaceuticals used to prevent, treat and cure allergies and disrupted microbial community associated with allergies in human and animal subjects
;
pharmaceuticals used to prevent, treat and cure metabolic disorders and disrupted microbial community associated with aforementioned conditions in human and animal subjects
;
pharmaceuticals used to prevent, treat and cure cardiovascular, neuro-degenerative, neuro-inflammatory and neuro-psychiatric diseases and disrupted microbial community associated with aforementioned conditions in human and animal subjects
;
pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of neoplastic conditions, pre-neoplastic conditions and disrupted microbial community associated with the aforementioned conditions
;
pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of inflammation, neuro-inflammation, and autoimmune diseases and disrupted microbial community associated with the aforementioned conditions
;
pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of allergies and disrupted microbial community associated with allergies
;
pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of metabolic disorders and disrupted microbial community associated with the aforementioned conditions
;
pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of cardiovascular, neuro-degenerative, neuro-inflammatory and neuro-psychiatric diseases and disrupted microbial community associated with the aforementioned conditions
;
live bacteria, inactivated bacteria, recombinant bacteria and bacterial extracts
;
biological preparations in the nature of microorganisms to prevent disease in the nature of neoplastic conditions and pre-neoplastic conditions in animal or human subjects
;
biological preparations in the nature of microorganisms to prevent disease in the nature of inflammation, neuro-inflammation, and autoimmune diseases in animal or human subjects
;
biological preparations in the nature of microorganisms to prevent disease in the nature of allergies in animal or human subjects
;
biological preparations in the nature of microorganisms to prevent disease in the nature of metabolic disorders in animal or human subjects
;
biological preparations in the nature of microorganisms to prevent disease in the nature of cardiovascular, neuro-degenerative, neuro-inflammatory and neuro-psychiatric diseases
;
biological preparations in the nature of microorganisms to treat and cure neoplastic conditions and pre-neoplastic conditions in animal or human subjects
;
biological preparations in the nature of microorganisms to treat and cure inflammation and autoimmune diseases in animal or human subjects
;
biological preparations in the nature of microorganisms to treat and cure allergies in animal or human subjects
;
biological preparations in the nature of microorganisms to treat and cure metabolic disorders and cardiovascular, neuro-degenerative, neuro-inflammatory and neuro-psychiatric diseases in animal or human subjects
;
biological preparations in the nature of microorganisms to maintain and restore health in animal or human subjects via treatment of inflammation, neuro-inflammation, autoimmune diseases, allergies, metabolic disorders, cardiovascular, neuro-degenerative, neuro-inflammatory and neuro-psychiatric diseases
;
biological preparations in the nature of microorganisms to maintain and restore health in animal or human subjects via treatment of neoplastic conditions and pre-neoplastic conditions
;
cultures of microorganisms and preparation of microorganisms in the nature of bacterial and bacteriological preparations, all for medical and veterinary purposes, the foregoing for medical purposes
;
vaccines
;
therapeutic vaccines
;
vaccine preparations
;
antibodies for medical purposes
;
monoclonal antibodies
;
biopharmaceuticals
;
biosimilars and biological preparations for medical purposes
;
biochemical preparations for medical purposes
;
test kits in this class
;
preparations, substances, reagents and agents for diagnostic and medical purposes
Class 42
:
Medical research
;
scientific research
;
pharmaceutical research
;
research and development services including scientific, medical, pharmaceutical, vaccine and biotechnology products research and development services
;
industrial analysis
;
clinical trials
;
conducting clinical trials
;
provision of testing facilities
;
management of scientific research projects
;
laboratory analysis and research
;
preparation of technical studies, technical reports, scientific reports
;
provision of research services and facilities, provision of research results, information and outcomes
;
provision of information, advisory and consultancy services relating to the aforementioned services including over a global computer network